Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings
Trends psychiatry psychother. (Impr.)
;
45: e20210247, 2023. tab, graf
Article
Dans Anglais
|
LILACS-Express
| LILACS
| ID: biblio-1509231
ABSTRACT
Abstract Introduction Obsessive-compulsive disorder (OCD) is the fourth most prevalent mental disorder and is a disabling condition. OCD is associated with anatomical and functional changes in the brain, in addition to dysfunctional cognitions. The treatments of choice are selective serotonin reuptake inhibitors, cognitive-behavioral therapy (CBT), and exposure and response prevention (ERP). Trial-based cognitive therapy (TBCT) is a recent and empirically validated psychotherapy with a focus on restructuring dysfunctional negative core beliefs (CBs). The objective of this study was to evaluate the efficacy of TBCT relative to ERP for treatment of OCD. Methods A randomized, single-blind clinical trial was conducted, randomizing 26 patients for individual treatment with TBCT (n = 12) or ERP (n = 14). The groups were evaluated at baseline, at the end of 3 months (12 sessions), and at 3, 6, and 12-month follow-ups. Results Both approaches reduced the severity of symptoms with large effect sizes. These results were maintained at the 12-month follow-up assessment. Conclusion TBCT may be a valid and promising treatment for this disorder.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Type d'étude:
Essai clinique contrôlé
/
Etude diagnostique
langue:
Anglais
Texte intégral:
Trends psychiatry psychother. (Impr.)
Thème du journal:
Psychiatrie
Année:
2023
Type:
Article
Pays d'affiliation:
Brésil
/
États-Unis d'Amérique
Institution/Pays d'affiliation:
NYC Cognitive Therapy/US
/
Universidade Estadual do Piauí/BR
/
Universidade Federal da Bahia/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS